Understanding Quality of Life for People with Motor Neurone Disease Who Use Tracheostomy Ventilation and Family Members: A Scoping Review
- PMID: 39199512
- PMCID: PMC11352738
- DOI: 10.3390/brainsci14080821
Understanding Quality of Life for People with Motor Neurone Disease Who Use Tracheostomy Ventilation and Family Members: A Scoping Review
Abstract
Tracheostomy ventilation (TV) can increase survival time for people living with motor neurone disease (MND); however, the use of TV varies between countries. Concerns regarding anticipated quality of life (QoL) are among the reasons given by healthcare professionals for not recommending this intervention, yet little is known about QoL in this context. This scoping review was conducted to examine the evidence on QoL for those with MND who use TV and family members involved in their care. Using the methodological guidance of the Joanna Briggs Institute, 23 papers were identified for inclusion, and findings were inductively analysed to identify key themes. We found that people living with MND tend to rate QoL post TV more positively than anticipated by healthcare professionals or family members. QoL was found to be related to positive relationships and activities the person could maintain. Feeling able to make a choice and an adequate level of financial resources were also important factors. Family members tended to experience lower QoL, associated with the uncertainty surrounding an emergency procedure and the complexity of subsequently required care. More evidence on QoL from the perspectives of people with MND who use TV is needed to support decision making and inform guidance.
Keywords: amyotrophic lateral sclerosis; family care; invasive ventilation; motor neurone disease; quality of life; tracheostomy ventilation; wellbeing.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
End of life decision making when home mechanical ventilation is used to sustain breathing in Motor Neurone Disease: patient and family perspectives.BMC Palliat Care. 2024 May 2;23(1):115. doi: 10.1186/s12904-024-01443-1. BMC Palliat Care. 2024. PMID: 38698397 Free PMC article.
-
Tracheostomy ventilation in motor neurone disease: a snapshot of UK practice.Amyotroph Lateral Scler Frontotemporal Degener. 2022 Feb;23(1-2):35-41. doi: 10.1080/21678421.2021.1916534. Epub 2021 May 8. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 33969757
-
The Use of Mechanical Ventilation Support at the End of Life in Motor Neurone Disease/Amyotrophic Lateral Sclerosis: A Scoping Review.Brain Sci. 2022 Aug 30;12(9):1162. doi: 10.3390/brainsci12091162. Brain Sci. 2022. PMID: 36138898 Free PMC article.
-
Understanding living with tracheostomy ventilation for motor neuron disease and the implications for quality of life: a qualitative study protocol.BMJ Open. 2023 Mar 13;13(3):e071624. doi: 10.1136/bmjopen-2023-071624. BMJ Open. 2023. PMID: 36914199 Free PMC article.
-
Tracheostomy in motor neurone disease.Pract Neurol. 2019 Dec;19(6):467-475. doi: 10.1136/practneurol-2018-002109. Epub 2019 Jul 4. Pract Neurol. 2019. PMID: 31273080 Review.
References
-
- McDermott C.J., Shaw P.J. Diagnosis and management of motor neurone disease. BMJ. 2008;336:658–662. doi: 10.1136/bmj.39493.511759.BE. - DOI - PMC - PubMed
-
- Andersen P.M., Abrahams S., Borasio G.D., De Carvalho M., Chio A., Van Damme P., Hardiman O., Kollewe K., Morrison K.E., Petri S., et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS). Revised report of an EFNS task force. Eur. J. Neurol. 2012;19:360–375. - PubMed
-
- National Institute for Health and Care Excellence (NICE) Motor Neurone Disease: Assessment and Management. Clinical Guideline [ng42] 2016. [(accessed on 9 September 2023)]. Available online: https://www.nice.org.uk/guidance/ng42.
-
- Hayashi N., Atsuta N., Yokoi D., Nakamura R., Nakatochi M., Katsuno M., Izumi Y., Kanai K., Hattori N., Taniguchi A., et al. Prognosis of amyotrophic lateral sclerosis patients undergoing tracheostomy invasive ventilation therapy in Japan. J. Neurol. Neurosurg. Psychiatry. 2020;91:285–290. doi: 10.1136/jnnp-2019-322213. - DOI - PubMed
-
- Takei K., Tsuda K., Takahashi F., Hirai M., Palumbo J. An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe. Amyotroph. Lateral Scler. Front. Degener. 2017;18:88–97. doi: 10.1080/21678421.2017.1361445. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources